Come and meet Rima Ait-Belkacem and Jonathan Stauber to discover all our capabilities. June 4- 8, 2017, in (...)Read more
Webinar on Immuno-Oncology by Rima AIT-BELKACEM, PhD
The webinar titled “Immuno-Oncology: Tryptophan-Kynurenine Microenvironment Tumor Metabolites Pathway Highlighted by (...)Read more
HD Biomarker Discovery
Biomarker are the key components for the evaluation of a disease or disease progression.
In order to satisfy efficacy or toxicity investigation, Imabiotech offers new approach of imaging to localize biomarkers of efficacy or toxicity in many different options:
- Disease state evaluation
- Disease progression
- Read-out or companion biomarker for efficacy evaluation
- Biomarker of drug toxicity
In a single experiment, ImaBiotech evaluates drug distribution with biomarkers using Multimaging platform (Link) which combines different imaging techniques to discover and colocalize drugs and biomarkers together.